Avoid drawing the needle through the rubber stopper (cap)
While everyones experience is unique, many people have lost 15% or more of their starting body weight with tirzepatide
In 2021 - 2022, a stronger dose, weekly injectable formulation of Semaglutide (brand name Wegovy) was approved by the US FDA as a medication for weight loss in patients with at least one weight related medical issue
A history of pancreatitis or severe gastrointestinal disease (such as gastroparesis) are not formal contraindications but are important precautions that require careful consideration
Semaglutide GLP-1, a revolutionary medication in the management of type 2 diabetes and weight loss , perfectly complements our holistic approach to health, providing patients with innovative solutions for better living
Connecting with experienced GLP-1 providers for personalized treatment has never been easier in Florida